Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

miR-381 induces sensitivity of breast cancer cells to doxorubicin by inactivation of MAPK signaling via FYN
Hailong Mi, Xiaochun Wang, Fang Wang, et al.
European Journal of Pharmacology (2018) Vol. 839, pp. 66-75
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma
Ling Wei, Xingwu Wang, Liyan Lv, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 295
Role of non-coding RNAs and RNA modifiers in cancer therapy resistance
Xinyi Zhang, Kai Xie, Honghua Zhou, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 205
Delivery of miR-381-3p Mimic by Mesenchymal Stem Cell-Derived Exosomes Inhibits Triple Negative Breast Cancer Aggressiveness; an In Vitro Study
Samaneh Shojaei, Seyed Mahmoud Hashemi, Hossein Ghanbarian, et al.
Stem Cell Reviews and Reports (2021) Vol. 17, Iss. 3, pp. 1027-1038
Closed Access | Times Cited: 73
FYN: emerging biological roles and potential therapeutic targets in cancer
Sanfei Peng, Yang Fu
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 37
Exploring the role of non-coding RNAs in autophagy
Soudeh Ghafouri‐Fard, Hamed Shoorei, Mahdi Mohaqiq, et al.
Autophagy (2021) Vol. 18, Iss. 5, pp. 949-970
Open Access | Times Cited: 51
MicroRNAs as the critical regulators of Doxorubicin resistance in breast tumor cells
Amir Sadra Zangouei, Maliheh Alimardani, Meysam Moghbeli
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 41
miR-200c increases the sensitivity of breast cancer cells to Doxorubicin through downregulating MDR1 gene
Sahar Safaei, Mohammad Amini, Shiva Najjary, et al.
Experimental and Molecular Pathology (2022) Vol. 125, pp. 104753-104753
Closed Access | Times Cited: 30
miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer
Evita M. Lindholm, Miriam R. R. Aure, Mads H. Haugen, et al.
Molecular Oncology (2019) Vol. 13, Iss. 10, pp. 2278-2296
Open Access | Times Cited: 43
Contribution of miRNAs in the Pathogenesis of Breast Cancer
Soudeh Ghafouri‐Fard, Ali Khanbabapour Sasi, Atefe Abak, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 34
FYN promotes gastric cancer metastasis by activating STAT3-mediated epithelial-mesenchymal transition
Jie Yu, Zhijun Zhou, Zhe-Wei Wei, et al.
Translational Oncology (2020) Vol. 13, Iss. 11, pp. 100841-100841
Open Access | Times Cited: 34
The role of microRNAs on doxorubicin drug resistance in breast cancer
Khadijeh Jamialahmadi, Fatemeh Zahedipour, Gholamreza Karimi
Journal of Pharmacy and Pharmacology (2021) Vol. 73, Iss. 8, pp. 997-1006
Open Access | Times Cited: 30
<p>EZH2 Contributes To Cisplatin Resistance In Breast Cancer By Epigenetically Suppressing miR-381 Expression</p>
Dongwei Dou, Xin Ge, Xinxing Wang, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 9627-9637
Open Access | Times Cited: 30
MicroRNAs as a clue to overcome breast cancer treatment resistance
Iris Garrido‐Cano, B. Pattanayak, Anna Adam‐Artigues, et al.
Cancer and Metastasis Reviews (2021) Vol. 41, Iss. 1, pp. 77-105
Open Access | Times Cited: 22
miR-381-3p suppresses breast cancer progression by inhibition of epithelial–mesenchymal transition
Yong-Zheng Yu, Qiang Mu, Qian Ren, et al.
World Journal of Surgical Oncology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 19
Hyaluronic Acid-Modified Nanoparticles Self-Assembled from Linoleic Acid-Conjugated Chitosan for the Codelivery of miR34a and Doxorubicin in Resistant Breast Cancer
Xiaoxia Yang, Pengfei Shang, Jianbo Ji, et al.
Molecular Pharmaceutics (2021) Vol. 19, Iss. 1, pp. 2-17
Closed Access | Times Cited: 18
Overexpression of FYN suppresses the epithelial-to-mesenchymal transition through down-regulating PI3K/AKT pathway in lung adenocarcinoma
Feng Xue, Yong Jia, Jian Zhao
Surgical Oncology (2020) Vol. 33, pp. 108-117
Closed Access | Times Cited: 18
LncRNA SNHG15 contributes to doxorubicin resistance of osteosarcoma cells through targeting the miR-381-3p/GFRA1 axis
Jinshan Zhang, Dan Rao, Haibo Ma, et al.
Open Life Sciences (2020) Vol. 15, Iss. 1, pp. 871-883
Open Access | Times Cited: 15
The role of miRNAs and lncRNAs in conferring resistance to doxorubicin
Mohammad Taheri, Bashdar Mahmud Hussen, Farhad Tondro Anamag, et al.
Journal of drug targeting (2021) Vol. 30, Iss. 1, pp. 1-21
Closed Access | Times Cited: 12
MicroRNA‐381 in human cancer: Its involvement in tumour biology and clinical applications potential
Huanhuan Sha, Yujie Gan, Feng Xu, et al.
Journal of Cellular and Molecular Medicine (2022) Vol. 26, Iss. 4, pp. 977-989
Open Access | Times Cited: 8
The Role of miRNAs in the Resistance of Anthracyclines in Breast Cancer: A Systematic Review
Zihan Si, Yan Zhong, Sixian Lao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
Meta analysis of bioactive compounds, miRNA, siRNA and cell death regulators as sensitizers to doxorubicin induced chemoresistance
Sruthi Sritharan, Sampurna Guha, Snoopy Hazarika, et al.
APOPTOSIS (2022) Vol. 27, Iss. 9-10, pp. 622-646
Closed Access | Times Cited: 7
MicroRNA-381—A Key Transcriptional Regulator: Its Biological Function and Clinical Application Prospects in Cancer
Xue Zeng, Zhe Cao, Wenhao Luo, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 8
Establishment and Validation of a Model for Disease-Free Survival Rate Prediction Using the Combination of microRNA-381 and Clinical Indicators in Patients with Breast Cancer
Jun Shen, Meng Wang, Li Fan, et al.
Breast Cancer Targets and Therapy (2022) Vol. Volume 14, pp. 375-389
Open Access | Times Cited: 3
Fyn, an important molecule in the brain, is a potential therapeutic target for brain tumours
Chongxi Xu, Yi Tang, Xing Lu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
miRNAs as short non-coding RNAs in regulating doxorubicin resistance
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Farhad Adhami Moghadam, et al.
Journal of Cell Communication and Signaling (2023) Vol. 17, Iss. 4, pp. 1181-1202
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top